Compound Detail
CHEMBL1641989
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1641989 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JFEJSBHDIHUJSI-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
452.4
MW (Da)
4.89
ALogP
5
HBA
2
HBD
81.0
PSA (Ų)
0.53
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.39
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.39 | 5.39 | 4100.0 | 1 |
| Myosin light chain kinase, smooth muscle CHEMBL2428 | IC50 | 4.6 | 4.6 | 25100.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 4100.0 | nM | 5.39 | Inhibition of EGFR by HTRF assay | 21130659 |
| Myosin light chain kinase, smooth muscle | IC50 | = | 25100.0 | nM | 4.6 | Inhibition of MLCK by HTRF assay | 21130659 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21130659 | 10.1016/j.bmc.2010.11.007 | Unchecked | 5 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Myosin light chain kinase, smooth muscle | 2 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Mitogen-activated protein kinase 3 | 2 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Serine/threonine-protein kinase MARK2 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | MAP kinase-interacting serine/threonine-protein kinase 2 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Epidermal growth factor receptor | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Rho-associated protein kinase 2 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Protein kinase C zeta type | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | MAP kinase-activated protein kinase 2 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | MAP kinase-activated protein kinase 5 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Glycogen synthase kinase-3 beta | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Cyclin-dependent kinase 2/cyclin A | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Serine/threonine-protein kinase STK11 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Casein kinase I isoform alpha | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Mitogen-activated protein kinase 10 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Serine/threonine-protein kinase Nek2 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Serine/threonine-protein kinase Nek6 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Serine/threonine-protein kinase PAK 6 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Ephrin type-B receptor 3 | 1 |
| 21130659 | 10.1016/j.bmc.2010.11.007 | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 1 |
Data from ChEMBL 36 via Core Engine